Physiologic variations of serum testosterone within the normal range do not affect serum prostate-specific antigen

Area of Science:

• Urology
• Endocrinology
• Oncology

Background:

• Prostate-specific antigen (PSA) is a key biomarker for prostate cancer detection.
• Testosterone levels fluctuate and may influence PSA concentrations.
• Investigating the relationship between testosterone and PSA is crucial for refining prostate cancer diagnostics.

Purpose of the Study:

• To investigate the correlation between endogenous total serum testosterone levels and serum PSA concentrations.
• To assess if testosterone-specific reference ranges can enhance PSA utility in prostate cancer screening.
• To determine if testosterone influences PSA as a tumor marker.

Main Methods:

• Serum PSA and total testosterone levels were measured in 150 men without a prior prostate cancer diagnosis.
• PSA was quantified using the Abbott IMX microparticle enzyme immunoassay.
• Total testosterone was determined via Coat-A-Count radioimmunoassay.

Main Results:

• No statistically significant correlation was observed between serum testosterone levels and PSA concentrations.
• This lack of correlation persisted even after adjusting for age and weight.
• The findings indicate no direct relationship between testosterone and PSA in the studied cohort.

Conclusions:

• Serum total testosterone levels do not appear to enhance the sensitivity or specificity of PSA as a prostate cancer tumor marker.
• Current diagnostic protocols relying on PSA do not require adjustment based on testosterone levels.
• Further research may explore other hormonal or clinical factors influencing PSA.